Le Lézard
Classified in: Health
Subject: PET

RxActuator Announces New Partnership with REM SYSTEMS


TUCSON, Ariz., Jan. 22, 2020 /PRNewswire-PRWeb/ -- RxActuator, Inc. is proud to announce its new partnership with REM SYSTEMS. RxActuator will be among the innovative products REM SYSTEMS has in its veterinary medicine range.

RxActuator, Inc. is the manufacturer of a proprietary and revolutionary veterinary medical device - the Mini-Infusertm Pump. This Wearable Subcutaneous Constant Rate Infusion (SQ-CRI) pump for animals is the first constant rate infusion pump designed specifically for animals.

REM SYSTEMS is a specialized medical equipment distribution company in Australia, Pacific Islands countries and New Zealand. They work to help medical and veterinary professionals deliver better patient outcomes through advanced treatments and efficient procedures. Visit https://www.remsystems.com.au/ to find out more.

"It is an absolute pleasure working with the team at RxActuator. Based on our experience to date, the Mini-Infuser has been very well received by our clients in Australia and New Zealand. We pride ourselves on offering innovative and high-quality solutions for the veterinary industry; RxActuator's products certainly complement our values and vision."

Dr. Matthew Jones BVSc
Technical Services and Operations Manager
REM SYSTEMS

To shop for RxActuator products including the revolutionary Mini-Infusertm Pump, please visit: https://www.rxactuator.net/shop/

Contact info/Media Inquiries:
Doug Nutter
Chief Marketing Officer
[email protected]
810-964-3248

SOURCE RxActuator, Inc.


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: